On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

The road to UNGASS 2016: Process and policy asks from IDPC
This document outlines the five main “asks” that the International Drug Policy Consortium members will collectively call for between now and the United Nations General Assembly Special Session (UNGASS) to be held in New York in the summer of 2016.
Supervised injection services: What has been demonstrated? A systematic literature review
Supervised injection services (SISs) have been developed to promote safer drug injection practices, enhance health-related behaviors among people who inject drugs, and connect them with external health and social services. Nevertheless, SISs have also been accused of fostering drug use and drug trafficking. This study collects and synthesizes the currently available evidence regarding SIS-induced benefits and harm.
An injection of reason: Critical analysis of bill C-2 in Canada
The Government of Canada devised Bill C-2 (An Act to amend the Controlled Drugs and Substances Act), a piece legislation that would make supervised consumption services harder to establish.
Yet another dimension of the ineffectiveness of supply-side interventions in illegal drug markets
The growing literature on the effectiveness of supply-side interventions in illegal drug markets shows that most measures taken to curb supply (crop eradication, drug seizures, arrests of drug traffickers and dealers, etc.) have very small effects on quantities transacted.
Médicos afirmam que saúde deve ser central nas políticas de drogas
IDHDP estarão presentes no Rio de Janeiro na conferência global 2016 (de 10 a 12 de Novembro). O propósito da sessão IDHDP na manhã do dia 11 será incidir sobre os problemas de drogas que estão afetando severamente a região latino-americana, e sugerir alternativas à base da saúde.
Drug policy, harm reduction and young people: USA
This case study offers an overview of some of the main drug policy issues facing young people in the USA, looking at the impacts of the drug policy and harm reduction on young people, drawing data and evidence from official national statistics and experiences of young people who use drugs themselves.
Advocacy for the human rights of People Who Use Drugs
This study examines how and to what extent advocacy for human rights of People who Use Drugs is currently used and how human rights advocacy can further improve the effectiveness of harm reduction strategies and services.
Drug-related deaths in Scotland in 2013
The Scottish statistics of drug-related deaths in 2013 and earlier years, broken down by age, sex, selected drugs reported, report that the death following opioid overdose have gone down by 41 because of naloxone programmes.
UNAIDS gap report: Beginning of the end of the AIDS epidemic
Although the number of people who are newly infected with HIV is declining, people who inject drugs are almost universally criminalised and have less access to HIV treatment.
Ketamine for depression: New review highlights the need for an RCT
Mainly used in veterinary surgery, ketamine has been discovered to rapidly improve even the most severe cases of unipolar and bipolar depression. However, as yet there are still many questions left unanswered before ketamine can become a licensed treatment alternative. This study provides a systematic review of methodologically sound studies.
Share this on: